Us Bancorp \De\ Regenxbio Inc. Transaction History

Us Bancorp \De\

$71.8 Billion
Q1 2024

A detailed history of Us Bancorp \De\ transactions in Regenxbio Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 6,422 shares of RGNX stock, worth $87,596. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,422

Previous 13,831 53.57%

Holding current value

$87,596

Previous $248,000 45.56%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$12.17 - $24.61 $90,167 - $182,335	-7,409 Reduced 53.57%	6,422 $135,000
Q4 2023 Feb 09, 2024	BUY	$12.89 - $20.82 $175,123 - $282,860	13,586 Added 5545.31%	13,831 $248,000
Q2 2023 Aug 09, 2023	BUY	$17.23 - $21.71 $637 - $803	37 Added 17.79%	245 $4,000
Q1 2023 May 09, 2023	SELL	$18.08 - $24.55 $415 - $564	-23 Reduced 9.96%	208 $3,000
Q4 2022 Feb 13, 2023	SELL	$20.4 - $24.73 $1,264 - $1,533	-62 Reduced 21.16%	231 $5,000

Q3 2022 Oct 27, 2022	SELL	$22.29 - $35.04 $4,770 - $7,498	-214 Reduced 42.21%	293 $8,000
Q2 2022 Aug 01, 2022	SELL	$19.35 - $35.04 $8,107 - $14,681	-419 Reduced 45.25%	507 $13,000
Q1 2022 May 11, 2022	BUY	$24.62 - $34.31 $3,496 - $4,872	142 Added 18.11%	926 $31,000
Q4 2021 Feb 11, 2022	BUY	$30.19 - $40.28 $4,649 - $6,203	154 Added 24.44%	784 $26,000
Q3 2021 Nov 10, 2021	BUY	$29.09 - $45.68 $6,603 - $10,369	227 Added 56.33%	630 $26,000
Q2 2021 Aug 05, 2021	BUY	$32.46 - $40.48 $7,076 - $8,824	218 Added 117.84%	403 $16,000
Q4 2020 Feb 04, 2021	BUY	$26.52 - $49.35 $4,906 - $9,129	185 New	185 $8,000
Q1 2020 May 13, 2020	SELL	$21.5 - $54.2 $838 - $2,113	-39 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$31.84 - $50.88 $477 - $763	-15 Reduced 27.78%	39 $1,000
Q4 2018 Feb 13, 2019	BUY	$39.11 - $75.15 $703 - $1,352	18 Added 50.0%	54 $2,000
Q3 2018 Nov 01, 2018	BUY	$65.0 - $82.15 $2,340 - $2,957	36 New	36 $3,000

Others Institutions Holding RGNX

# of Institutions

192

Shares Held

42.6M

Call Options Held

80.6K

Put Options Held

55.2K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $590M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account